Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.47 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.45 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.45 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.45 |
| ▸ | RRM1 | P23921 | 1/20 | 0.44 |
| ▸ | S1PR2 | O95136 | 2/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.36 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.36 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.36 |
| ▸ | DPP4 | P27487 | 1/20 | 0.36 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13205415 | 0.87 | DPP7 (0.51) | DPP7GNAI3GNAO1GNAI1RRM1 | |
| SCHEMBL10062328 | 0.86 | GNAI3 (0.64) | DPP7GNAI3GNAO1GNAI1RRM1 | |
| SCHEMBL14116004 | 0.85 | DPP7 (0.46) | DPP7GNAI3GNAO1GNAI1RRM1 | |
| SCHEMBL16803297 | 0.83 | DPP7 (0.42) | DPP7GNAI3GNAO1GNAI1RRM1 | |
| SCHEMBL18133012 | 0.81 | DPP7 (0.46) | DPP7GNAI3GNAO1GNAI1RRM1 | |
| SCHEMBL632876 | 0.80 | KDM4E (0.46) | — | |
| SCHEMBL26224675 | 0.80 | DPP7 (0.69) | DPP7GNAI3GNAO1GNAI1RRM1 | |
| SCHEMBL14845859 | 0.80 | DPP7 (0.55) | DPP7GNAI3GNAO1GNAI1RRM1 | |
| SCHEMBL16309325 | 0.78 | KDM4E (0.44) | — | |
| SCHEMBL13044202 | 0.77 | GNAI3 (0.56) | DPP7GNAI3GNAO1GNAI1RRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7829341-B2 | Polyviologen boronic acid quenchers for use in analyte sensors | GLUMETRICS, INC. (US) | 2010-11-09 | — | — | US | disclosed |
| US-20090081803-A1 | POLYVIOLOGEN BORONIC ACID QUENCHERS FOR USE IN ANALYTE SENSORS | GLUMETRICS INC. (US) | 2009-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090081803-A1 | POLYVIOLOGEN BORONIC ACID QUENCHERS FOR USE IN ANALYTE SENSORS | SLC2A4, SLC2A2, SLC2A1 | DPP7 614/4885GNAI3 625/4885GNAO1 1177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.